Myriad Genetics Inc
Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Salt Lake City, UT
MYGN chart
What traders are saying about $MYGN
Latest postsMyriad Genetics Inc news
- BlackRock Portfolio Management Discloses 8.6% Stake in Myriad Genetics Inc
Kalkine Media ·
- Myriad Genetics cuts FY26 revenue guidance by $90M, faces securities probe
scanx.trade ·
- Weekly Recap: Myriad prenatal business acquisition and BioReference asset buy
TradingView ·
- Labcorp inks Millennium Health buyout to add drug testing services
medtechdive.com ·
- Myriad Genetics probe expands after 47% stock plunge and guidance cut
scanx.trade ·
- Myriad Genetics FY26 Sales Guidance Cut to $770-$790M
scanx.trade ·
- Myriad Genetics, Inc. (MYGN) stock price, news, quote and history
Yahoo Finance Singapore ·
- Myriad Genetics, Inc. Estimates – NASDAQ:MYGN
TradingView ·
- What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call
marketbeat.com ·
- Myriad Genetics unveils new MONSTAR-SCREEN-3 data on WGS-based Precise MRD platform
Traders Union ·
- Myriad Genetics presents data on cancer recurrence detection test
Investing.com ·
- Myriad Genetics (MYGN) Stock Sees Fair Value Lift After Split Analyst Revisions
Yahoo Finance ·
Myriad Genetics Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $824.5M | $837.6M | $753.2M | $678.4M |
| Net income | -$366.0M | -$127.0M | -$263.0M | -$112.0M |
| Diluted EPS | $-3.95 | $-1.41 | $-3.18 | $-1.39 |
| Total assets (year end) | $706.6M | $1.03B | $1.15B | $1.20B |
| Cash and equivalents (year end) | $149.6M | $102.4M | $132.1M | $56.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Myriad Genetics Inc
- Ticker
- MYGN (Nasdaq)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Salt Lake City, UT
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 899923
- Former names
- MYRIAD GENETICS INC
Frequently asked questions
What exchange is Myriad Genetics Inc listed on?
Myriad Genetics Inc trades on the Nasdaq under the ticker symbol MYGN.
What industry is Myriad Genetics Inc in?
Myriad Genetics Inc is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is Myriad Genetics Inc headquartered?
Myriad Genetics Inc's business address on file with the SEC is in Salt Lake City, UT.
When does Myriad Genetics Inc's fiscal year end?
Myriad Genetics Inc's fiscal year ends on December 31.
How much revenue did Myriad Genetics Inc report?
Myriad Genetics Inc reported $824.5M in revenue for calendar year 2025, according to its SEC filings.